Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Beuzard

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Genetic Vaccines and Therapy|March 13, 2008
Careful adjustment of Epo non-viral gene therapy for beta-thalassemic anaemia treatmentEmmanuelle E Fabre, Pascal Bigey, Yves Beuzard, et al.
Methods in Enzymology|February 28, 2012
Lentivirus vectors in β-thalassemiaEmmanuel Payen, Charlotte Colomb, Olivier Negre, et al.
Experimental Hematology|February 26, 2008
Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietinOlivier Negre, Floriane Fusil, Annie Henri, et al.
Blood|November 16, 2002
ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD miceJonathan W Stocker, Lucia De Franceschi, Grant A McNaughton-Smith, et al.
Human Gene Therapy|March 18, 2008
Therapy of anemia in kidney failure, using plasmid encoding erythropoietinPeggy Richard-Fiardo, Emmanuel Payen, Raphaël Chèvre, et al.
Proteomics. Clinical Applications|December 8, 2010
Heat-shock protein-27, -70 and peroxiredoxin-II show molecular chaperone function in sickle red cells: Evidence from transgenic sickle cell mouse modelAndrea Biondani, Franco Turrini, Franco Carta, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2002
Long-term doxycycline-regulated secretion of erythropoietin by encapsulated myoblastsBirgit Sommer, Christopher Rinsch, Emmanuel Payen, et al.
Critical Care Medicine|December 15, 2006
Decrease in lung nitric oxide production after peritonitis in mice with sickle cell diseasePablo Bartolucci, Minh-Triet Ngo, Yves Beuzard, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 5, 2008
Protective effects of phosphodiesterase-4 (PDE-4) inhibition in the early phase of pulmonary arterial hypertension in transgenic sickle cell miceLucia De Franceschi, Orah S Platt, Giorgio Malpeli, et al.
Blood|March 26, 2011
Correction of murine β-thalassemia after minimal lentiviral gene transfer and homeostatic in vivo erythroid expansionOlivier Negre, Floriane Fusil, Charlotte Colomb, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Genetic Vaccines and Therapy|March 13, 2008
Careful adjustment of Epo non-viral gene therapy for beta-thalassemic anaemia treatmentEmmanuelle E Fabre, Pascal Bigey, Yves Beuzard, et al.
Methods in Enzymology|February 28, 2012
Lentivirus vectors in β-thalassemiaEmmanuel Payen, Charlotte Colomb, Olivier Negre, et al.
Experimental Hematology|February 26, 2008
Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietinOlivier Negre, Floriane Fusil, Annie Henri, et al.
Blood|November 16, 2002
ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD miceJonathan W Stocker, Lucia De Franceschi, Grant A McNaughton-Smith, et al.
Human Gene Therapy|March 18, 2008
Therapy of anemia in kidney failure, using plasmid encoding erythropoietinPeggy Richard-Fiardo, Emmanuel Payen, Raphaël Chèvre, et al.
Proteomics. Clinical Applications|December 8, 2010
Heat-shock protein-27, -70 and peroxiredoxin-II show molecular chaperone function in sickle red cells: Evidence from transgenic sickle cell mouse modelAndrea Biondani, Franco Turrini, Franco Carta, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2002
Long-term doxycycline-regulated secretion of erythropoietin by encapsulated myoblastsBirgit Sommer, Christopher Rinsch, Emmanuel Payen, et al.
Critical Care Medicine|December 15, 2006
Decrease in lung nitric oxide production after peritonitis in mice with sickle cell diseasePablo Bartolucci, Minh-Triet Ngo, Yves Beuzard, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 5, 2008
Protective effects of phosphodiesterase-4 (PDE-4) inhibition in the early phase of pulmonary arterial hypertension in transgenic sickle cell miceLucia De Franceschi, Orah S Platt, Giorgio Malpeli, et al.
Blood|March 26, 2011
Correction of murine β-thalassemia after minimal lentiviral gene transfer and homeostatic in vivo erythroid expansionOlivier Negre, Floriane Fusil, Charlotte Colomb, et al.
Pageof 3